Health
Western Countries Sending Alzheimer’s Patients to Thailand for Care

Residents of this facility for people with Alzheimer’s disease toss around a yellow ball and laugh under a cascade of water with their caregivers, in a swimming pool ringed by palm trees and wind chimes. Susanna Kuratli, once a painter of delicate oils, swims a lap and smiles.
Watching is her husband, Ulrich, who has a heart-rending decision: to leave his wife of 41 years in this facility 9,000 kilometres from home, or to bring her back to Switzerland.
Their homeland treats the elderly as well as any nation on earth, but Ulrich Kuratli says the care here in northern Thailand is not only less expensive but more personal. In Switzerland, “You have a cold, old lady who gives you pills and tells you to go to bed,” he says.
Kuratli and his three grown children have given themselves six months to decide while the retired software developer lives alongside his 65-year-old wife in Baan Kamlangchay — “Home for Care from the Heart.” Patients live in individual houses within a Thai community, are taken to local markets, temples and restaurants, each with three caretakers working in rotation to provide personal around-the-clock care. The monthly $3,800 cost is a third of what basic institutional care would come to in Switzerland.
Kuratli is not yet sure how he will care for Susanna, who used to produce a popular annual calendar of her paintings. But he’s leaning toward keeping her in Thailand, possibly for the rest of her life.
“Sometimes I am jealous. My wife won’t take my hand but when her Thai carer takes it, she is calm. She seems to be happy,” he says. “When she sees me she starts to cry. Maybe she remembers how we were and understands, but can no longer find the words.”
Western nations confronting Alzheimer’s
Spouses and relatives in Western nations are increasingly confronting Kuratli’s dilemma as the number of Alzheimer’s patients and costs rise, and the supply of qualified nurses and facilities struggles to keep up. Faraway countries are offering cheaper, and to some minds better, care for those suffering from the irreversible loss of memory.
The nascent trend is unnerving to some experts who say uprooting people with Alzheimer’s will add to their sense of displacement and anxiety, though others say quality of care is more important than location. There’s also some general uneasiness over the idea of sending ailing elderly people abroad: The German press has branded it “gerontological colonialism.”
Germany is already sending several thousand sufferers, as well as the aged and otherwise ill, to Eastern Europe, Spain, Greece and Ukraine. Patients are even moving from Switzerland, which was ranked No. 1 in health care for the elderly this year in an index compiled by the elderly advocacy group HelpAge International and the UN Population Fund.
Facilities in Thailand also are preparing to attract more Alzheimer’s sufferers. In Chiang Mai, a pleasant city ringed by mountains, Baan Kamlangchay will be followed by a $10-million, holidaylike home scheduled to open before mid-2014. Also on the way is a small Alzheimer’s unit within a retirement community set on the grounds of a former four-star resort. With Thailand seeking to strengthen its already leading position as a medical tourism and retirement destination, similar projects are likely.
The number of people over 60 worldwide is set to more than triple between 2000 and 2050 to 2 billion, according to the World Health Organization. And more are opting for retirement in lower-cost countries.
“Medical tourism” has become a booming industry, with roughly 8 million people a year seeking treatment abroad, according to the group Patients Without Borders.
44 million Alzheimer’s patients globally
The U.K.-based Alzheimer’s Disease International says there are more than 44 million Alzheimer’s patients globally, and the figure is projected to triple to 135 million by 2050. The Alzheimer’s Association estimates that in the U.S. alone, the disease will cost $203 billion this year and soar to $1.2 trillion by 2050.
The pioneering Baan Kamlangchay was established by Martin Woodtli, a Swiss who spent four years in Thailand with the aid group Doctors Without Borders before returning home to care for his mother who had been diagnosed with Alzheimer’s.
Wanting to return to Thailand and knowing that Thais traditionally regard the elderly with great respect, he brought his mother to Chiang Mai, where she became the home’s first “guest.” Woodtli never uses the word “patient.”
Over the next 10 years, the 52-year-old psychologist and social worker purchased or rented eight two-storey houses where 13 Swiss and German patients now reside. Two people normally share the modest but well-kept, fully furnished houses, each sleeping in a separate bedroom along with their caretaker.
Breakfast and lunch are eaten together at another residence where Woodtli, his wife and son live. On most afternoons, the group gathers at a private, walled park to swim, snack and relax on deck chairs. Regular outside activities are organized because he believes these stimuli may help delay degeneration.
Thailand is not the answer for everyone with Alzheimer’s
“Movement is important. Tensions are also relieved if they have freedom to move. Our carers allow our guests a lot of space as long as it does not pose a danger to them,” he says. “In Switzerland we don’t have opportunity for such care.”
He says his guests “cannot explain it, but I think they feel part of a family, a community, and that is very important.”
Yet Woodtli says he has received criticism about “the Swiss starting to export their social problems.”
The German press has recently described shifting the aged and ailing abroad as “grandmother export.”
Sabine Jansen, head of Germany’s Alzheimer Society, says that while some with Alzheimer’s may adjust to an alien place, most find it difficult because they live in a world of earlier memories.
“People with dementia should stay in their familiar environment as long as possible. They are better oriented in their own living places and communities,” she says. “Friends, family members, neighbours can visit them. Also because of language and cultural reasons, it is best for most to stay in their home country.”
Facility being built in the outlying Chiang Mai
Angela Lunde of the U.S.-based Mayo Clinic says that generally the afflicted do better in a familiar environment, but over time, even those with advanced stages of the disease can adjust well. “I think a positive transition has less to do with the move itself and more with the way in which the staff and new environment accommodates the person living with dementia,” she says.
Woodtli agrees that moving to country like Thailand is not the answer for everyone with Alzheimer’s, but those who have travelled widely and are accustomed to change can probably adapt.
“One of our guests sometimes wakes up in the morning and says, ‘Where am I?’ But she would do the same if she was in a care centre in Switzerland,” he says. “And they take their past with them. One guest thinks she is in a schoolhouse at Lake Lucerne.”
Those who end up staying at a facility being built in the outlying Chiang Mai district of Doi Saket will have amenities that would be tough for its European counterparts to match, including a clubhouse with a massage room and beauty parlour, a restaurant, Swiss bakery and pavilions with soaring ceilings and skylights.
“The idea is that this is a resort, not a hospital,” says Marc H. Dumur, a veteran hotelier who will manage the Swiss-owned, 3.5-hectare facility built amid orchards and groves of teak. Going up are 72 patient rooms in six spacious pavilions, plus villas for visiting family members. Around-the-clock care will be provided by a staff of 150, including a Swiss head nurse and at least one licensed Thai nurse for each pavilion.
These patient-to-carer ratios reflect the costs in a developing country like Thailand and the West. A licensed Thai nurse earns less than $700 a month, compared to about $7,000 for one in Switzerland, where care centres will have one nurse responsible for 10 patients.
Care at the Doi Saket home will cost $6,000 a month, roughly what a mid-level employee in Switzerland would receive as a pension, Dumur says.
Generous national health insurance
A number of European countries have generous national health insurance, but these generally do not cover treatment abroad. Kuratli says the Swiss government would cover two-thirds of the bill for his wife’s care if she stays in Switzerland, but since high-end private clinics there can cost $15,000 or more per month, he could still end up paying more there than he would in Thailand.
Woodtli agrees that it is crucial “for the patients to be together with their carers, to know and trust.” He says Thai caregivers like those at Baan Kamlangchay are generally more emotionally and physically engaged with their charges.
At the swimming pool, Madeleine Buchmeier snaps photos and laughs as she watches a caregiver take her smiling husband’s hands to twirl around together in a dance out of childhood.
He used to sink when entering water. In the three weeks since they arrived, her husband has calmed down and can swim again, all while his medicine is being sharply reduced.
Geri used to bang his head against the walls of a care facility in Switzerland, says Madeleine, “as if he wanted to do something, get somewhere.”
Like Kuratli, Buchmeier is deciding whether her 64-year-old husband should stay or go back to Switzerland. Once a Ford Motor Co. employee who spoke four languages, he now mutters largely disjointed sentences but appears to recognize his wife.
“It’s a miracle,” she says. – By: DENIS D. GRAY Associated Press
Health
Report Causes Pfizer Stock to Climb Approximately $1 Billion Acquired by Starboard

(VOR News) – According to a rumor that activist investor Pfizer Starboard Value has taken a holding in the struggling pharmaceutical business that is expected to be worth around one billion dollars, the stock of Pfizer (PFE) is on the increase in premarket trading on Monday.
This comes after the report was made public. The report was made available to the general public following this. Starboard Value was successful in moving forward with the acquisition of the position.
Starboard is said to have approached Ian Read, a former chief executive officer of Pfizer, and Frank D’Amelio, a former chief financial officer, in order to seek assistance with its goals of boosting the performance of the company, according to the Wall Street Journal. Read and D’Amelio are both former Pfizer executives.
The purpose of this is to facilitate the accomplishment of its objectives, which include enhancing the overall performance of the firm.
In their previous jobs, D’Amelio and Read were chief financial officers.
It is stated in the report that the hedge fund is of the opinion that Pfizer, which is currently being managed by Albert Bourla, who succeeded Read as Chief Executive Officer (CEO) in 2019, does not demonstrate the same level of mergers and acquisitions (M&A) discipline that Read did. Bourla took over for Read in 2019. Read was succeeded by Bourla in the year 2019.
Pfizer, a multinational pharmaceutical conglomerate, has made substantial investments in the acquisition of more companies that are involved in the research and development of cancer medicines.
These businesses have been acquired for billions of dollars. The biotechnology company Seagen, which was acquired by Pfizer in the previous year for a price of $43 billion, is included in this category. One of the businesses that can be classified as belonging to this category is Seagen.
In spite of the fact that the S&P 500 Index experienced a 21% increase in 2024.
No major trading occurred in Pfizer stock that year.
Due to the fact that the demand for Pfizer’s COVID-19 vaccines fell after the firm reached its pandemic peak in 2021, the share price of the corporation has decreased by over fifty percent since that time.
This drop has occurred ever since the company’s shares reached their maximum peak, which was during the time that this decline occurred. Not only have they not changed at all, but they have also remained essentially stable. This is in contrast to the S&P 500, which has gained 21% since the beginning of this year.
Recently, the corporation was forced to take a hit when it decided to recall all of the sickle cell illness medications that it had distributed all over the world.
Fears that the prescription could lead patients to experience severe agony and possibly even death were the impetus for the decision to recall the product. In spite of the fact that Pfizer’s stock is increasing by almost three percent as a result of the news that followed the company’s decision, this is the circumstance that has come about.
SOURCE: IPN
SEE ALSO:
New Study Reveals Drinking Soda Pop Increases the Risk of Stroke
The Mpox Vaccine’s Protection Decreases Within a Year; Booster Requirements
Health
New Study Reveals Drinking Soda Pop Increases the Risk of Stroke

A recent report from global research indicates that excessive consumption of coffee or soda pop is associated with an increased risk of stroke, although the intake of black and green tea is correlated with a reduced risk. Excessive consumption of soda pop or coffee warrants caution!
Recent research indicates that it may substantially elevate the risk of stroke.
Consuming four cups of coffee daily elevates the risk of stroke, according to studies, although ingesting 3-4 cups of black or green tea daily typically offers protection against stroke. Additionally, consume more coffee; it may reduce your risk of mortality.
Recent findings from global research studies co-led by the University of Galway and McMaster University, alongside an international consortium of stroke researchers, indicate that soda, encompassing both sugar-sweetened and artificially sweetened variants such as diet or zero sugar, is associated with a 22 percent heightened risk of stroke. The risk escalated significantly with the consumption of two or more of these beverages daily.
Stroke Risk Fizzy Drinks and Soda Pop
The correlation between fizzy drinks consumption and stroke risk was most pronounced in Europe, the Middle East, Africa, and South America. Women exhibit the most elevated risk of stroke from bleeding (intracranial hemorrhage) associated with fruit juice beverages. Consuming over 7 cups of water daily diminishes the likelihood of stroke due to a clot.
Researchers observed that numerous items advertised as fruit juice are derived from concentrates and have added sugars and preservatives, potentially negating the advantages often associated with fresh fruit and instead elevating stroke risk.
Fruit juice beverages were associated with a 37 percent heightened risk of stroke resulting from bleeding (intracranial hemorrhage). Consuming two of these beverages daily increases the risk thrice.
Consuming over four cups of coffee daily elevates the risk of stroke by 37 percent, although lower consumption levels do not correlate with stroke risk. Conversely, tea consumption was associated with an 18-20 percent reduction in stroke risk. Additionally, consuming 3-4 cups daily of black tea, such as Breakfast and Earl Grey varieties, excluding green and herbal teas, was associated with a 29 percent reduced risk of stroke.
Consuming 3-4 cups of green tea daily was associated with a 27 percent reduction in stroke risk. Notably, the addition of milk may diminish or inhibit the advantageous effects of antioxidants present in tea. The lower risk of stroke associated with tea consumption was negated for individuals who added milk.
Disclaimer: This article is intended solely for informational reasons and should not be considered a replacement for professional medical counsel. Consistently consult your physician regarding any inquiries pertaining to a medical problem.
Related News:
Starbucks Faces Sales Decline Amid Price Fatigue and Rising Competition
Starbucks Faces Sales Decline Amid Price Fatigue and Rising Competition
Health
Following a Diagnosis of Breast Cancer, What Else Should You Know?

(VOR News) – Even though breast cancer affects one in eight American women, receiving a diagnosis can make a woman feel isolated.
Experts in breast cancer from the American College of Physicians (ACS) advise patients on how to manage their disease so that they may better cope with this awful information.
First, the kind and stage of breast cancer dictates the course of your care.
In addition to immunotherapy and chemotherapy, there are various surgical options available for the treatment of breast cancer.
Women of African descent are disproportionately affected by triple-negative breast cancer, an extremely aggressive form of the disease that has never proven easy to treat.
According to the American Cancer Society, pembrolizumab (Keytruda), an immunotherapy, has been shown to be helpful when combined with chemotherapy and is currently the recommended course of treatment for certain combinations of triple-negative breast cancer.
In her presentation, Dr. Katharine Yao said, “It’s really important that the patient and physician discuss the patient’s preferences and values when deciding what type of treatment to pursue and that they have an honest, individualized discussion with their care team.”
She is currently responsible for developing breast cancer treatment recommendations for more than 575 hospitals and institutions nationwide in her role as chair of the American College of Surgeons’ National Accreditation Program for Breast Institutions (NAPBC).
Yao, vice chair of research at Endeavor Health NorthShore Hospitals in New York, pointed out that each decision made about a patient’s treatment plan should take her preferences and diagnosis into consideration.
She ought to think about whether she would prefer a mastectomy—a surgical procedure that involves removing the entire breast with or without reconstruction—or a lumpectomy, which involves a surgical procedure that spares part of the breast tissue.
She stated that “the breast cancer you have may be very different from the breast cancer you hear about in your neighbor, colleague, or friend” in a press release issued by the American Cancer Society (ACS).
“Consider that while discussing breast cancer with others.”
Throughout your journey, it is critical that you look after your emotional health because having breast cancer may have a detrimental impact on your mental health.
“Getting a cancer diagnosis does not mean that everything in your life stops to be normal.” Director of the Fellowship in the Diseases of the Breast program at the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas and state head of the American Cancer Society Commission on Cancer for Arkansas, Dr. Daniela Ochoa She thinks adding the burden of a cancer diagnosis and treatment to all the other pressures in life may be taxing.
“Managing stress and emotional health is vital component of a treatment plan.”
Ochoa recommends clinically trained psychologists and social workers who have assisted people in coping with cancer to anyone receiving treatment. Learning coping techniques might also be facilitated by joining cancer support groups or cancer wellness initiatives.
Breast cancer specialists say your care team is crucial.
The American Cancer Society (ACS) defines comprehensive care as having support at every stage of the procedure from surgeons, oncologists, patient navigators, nurses, social workers, psychologists, and other specialists.
After receiving a breast cancer diagnosis, women should see a surgeon or medical oncologist to explore their options; nevertheless, treatment shouldn’t be discontinued after just one appointment or after surgery is over.
Additionally, you can ask trustworthy friends or family members to accompany you to appointments and aid you with research or notes. They could serve as a network of support for you.
Yao stated in his talk that “one of the most important things is that patients should search out a team they have confidence in, that they trust will have their back when they need it, and a team they feel they can get access to and that will help them when they are in need.”
SOURCE: MP
SEE ALSO:
The Mpox Vaccine’s Protection Decreases Within a Year; Booster Requirements
COVID was a Paradigm Shift in Health Policymaking, Says Commissioner Stella Kyriakides.
Rwanda Reports 8 Deaths Linked To Ebola-Like Marburg Virus Days After It Declared An Outbreak
-
News3 years ago
Let’s Know About Ultra High Net Worth Individual
-
Entertainment2 years ago
Mabelle Prior: The Voice of Hope, Resilience, and Diversity Inspiring Generations
-
Health3 years ago
How Much Ivermectin Should You Take?
-
Tech2 years ago
Top Forex Brokers of 2023: Reviews and Analysis for Successful Trading
-
Lifestyles2 years ago
Aries Soulmate Signs
-
Movies2 years ago
What Should I Do If Disney Plus Keeps Logging Me Out of TV?
-
Health3 years ago
Can I Buy Ivermectin Without A Prescription in the USA?
-
Learning2 years ago
Virtual Numbers: What Are They For?